Desktop Site
|
18 Jul 24 | 12:19
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
BSE SENSEX
80,799.07
+82.52
+0.10 %
Corporate Announcement
Security Code
542934
Company
Chandra Bhagat Pharma Ltd
Exchange Received Time
29/04/2024 21:37:55
Exchange Disseminated Time
29/04/2024 21:37:56
Time Taken
00:00:01
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
4/29/2024 9:37:56 PM
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No.
Particulars
Details
1
Name of Company
Chandra Bhagat Pharma Ltd
2
CIN NO.
U24230MH2003PLC139534
3
Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)
14.88
4
Highest Credit Rating during the previous FY
NA
4a
Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)
Not Applicable
5
Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework
BSE
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No
Name of the Company Secretary: RAJNI DAWANI
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: cbcaccts@gmail.com
Name of the Chief Financial Officer: PRACHI BHAGAT
Designation: CFO
EmailId: cbcaccts@gmail.com
Date: 29/04/2024
Note:
In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Attachment
<< Back
Recently Viewed